To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dua ...

One in five older adults gets an infection up to six months after heart surgery—with women far more likely to develop one, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Driven by rising rates of high blood pressure, obesity, and other key risk factors, heart disease remains the leading cause ...

The progression of evidence has marched forward from studies showing a reduction in salt associated with lower blood pressure ...

One in five older adults gets an infection up to six months after heart surgery - with women far more likely to develop one, ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Dr. Peter Gliebus, director of cognitive and behavioral neurology at Marcus Neuroscience Institute, spoke to WPBF 25 about ...

A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug ...